バイオチップ市場- 世界の産業規模、シェア、動向、機会、予測、技術別、タイプ別、用途別、エンドユーザー別、地域別セグメント、競合、2020年～2030年

世界のバイオチップ市場は、2024年に158億2,000万米ドルと評価され、2030年までのCAGRは14.46%で、予測期間には356億5,000万米ドルに達すると予測されています。

バイオチップは、複数の生化学反応を同時に行い、所要時間を短縮するように設計された小型医療機器です。バイオチップは、固体基板上に配置されたマイクロテストサイトまたはマイクロアレイで構成されています。バイオチップには、DNA、タンパク質、酵素、ラボオンチップなど様々な形態があります。これらのコンパクトで強力なデバイスは使い勝手がよく、正確で重要な洞察を提供します。特に個人の医療情報や財務情報の保存に適しており、個人の追跡にも利用できます。体内に埋め込まれたバイオチップは、患者の健康状態や生物学的プロセスのモニタリング、分析、制御を支援します。さらに、危険の特定、安全な環境の確保、意思決定の改善にも貢献します。その結果、バイオチップは遺伝子診断、腫瘍診断、炎症診断、分子分析など、世界中で広く応用されています。

個別化医療と迅速診断に対する需要の高まりが、ヘルスケアと研究分野でのバイオチップの採用を大きく後押ししています。ゲノミクス、プロテオミクス、マイクロ流体工学の進歩に伴い、バイオチップは遺伝子疾患、がんバイオマーカー、感染症を早期に検出するための不可欠なツールになりつつあります。単一のサンプルからハイスループットで多重化されたデータを提供できるバイオチップは、臨床と研究所の両方の場面で不可欠なものとなっています。さらに、人工知能とクラウドコンピューティングの統合は、リアルタイムのデータ分析、パターン認識、予測診断を可能にすることでバイオチップの性能をさらに高め、最終的には患者の転帰とヘルスケア効率を向上させています。

主要市場促進要因

個別化医療におけるバイオチップ利用の拡大

主な市場課題

バイオハッキングの可能性の高さとプライバシーへの懸念

主要市場動向

アレルギー検出用バイオチップの採用増加

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のバイオチップ市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 技術別（マイクロアレイ、マイクロ流体）
  • タイプ別（DNAチップ、ラボオンチップ、プロテインチップ、その他）
  • 用途別（創薬・開発、疾患診断、ゲノミクス、プロテオミクス、体外診断、その他）
  • エンドユーザー別（病院・診断センター、学術・研究機関、バイオテクノロジー・製薬会社、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米のバイオチップ市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のバイオチップ市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域のバイオチップ市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米のバイオチップ市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのバイオチップ市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品発売

第13章 世界のバイオチップ市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Abbott Laboratories Inc.
• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• Fluidigm Corporation
• Thermo Fisher Scientific Inc.
• PerkinElmer Inc.
• Illumina Inc.
• Phalanx Biotech Group Inc.
• BioMerieux SA
• Qiagen NV

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Biochip Market was valued at USD 15.82 billion in 2024 and is expected to reach USD 35.65 billion in the forecast period with a CAGR of 14.46% through 2030. Biochips are miniature medical devices designed to perform multiple biochemical reactions simultaneously, reducing the required time. They consist of micro-test sites or microarrays arranged on a solid substrate. Biochips are available in various forms, including DNA, protein, enzyme, and lab-on-a-chip. These compact and powerful devices are user-friendly and provide accurate critical insights. They are particularly suitable for storing personal medical and financial information and can be used for tracking individuals. Implanted in the body, biochips assist in monitoring, analyzing, and controlling patient health and biological processes. Additionally, they contribute to hazard identification, ensuring a safe environment, and improving decision-making. Consequently, biochips have widespread applications in gene, oncology, and inflammatory diagnosis, as well as molecular analysis worldwide.

The growing demand for personalized medicine and rapid diagnostics is significantly fueling the adoption of biochips across healthcare and research sectors. With advancements in genomics, proteomics, and microfluidics, biochips are becoming essential tools for detecting genetic disorders, cancer biomarkers, and infectious diseases at an early stage. Their ability to deliver high-throughput, multiplexed data from a single sample makes them indispensable in both clinical and laboratory settings. Moreover, the integration of artificial intelligence and cloud computing is further enhancing biochip performance by enabling real-time data analysis, pattern recognition, and predictive diagnostics, ultimately improving patient outcomes and healthcare efficiency.

Key Market Drivers

Growing Use of Biochips in Personalized Medicine

Biochips are revolutionizing point-of-care and molecular diagnostics, fueling their tremendous uptake in personalized medicine. They enable clinicians to distinguish between healthy and malignant cells with unprecedented speed and accuracy. Industry data show that over 65% of cancer therapy protocols now incorporate biochip-based diagnostics to identify cell surface markers. Their capacity for whole-proteome analysis using minimal sample volume has transformed protein-based drug development, leading to 40% faster turnaround in therapeutic evaluations across research labs.

Their importance at the point of care is underscored by their performance in rapid diagnostic settings-over 70% of emerging POC diagnostic tools launched in 2024 utilize biochips. These compact devices support diagnosis with a tiny blood or tissue sample, accelerating decision-making in oncology, autoimmune disorders, and metabolic diseases. They also reduce patient burden by avoiding larger invasive sampling, making them ideal for chronic-condition monitoring. Healthcare providers increasingly rely on biochips for real-time biomarker detection, particularly in outpatient or remote-care environments.

A notable advantage is the precise detection of multiple biomarkers from a single sample without compromising accuracy. Recent evaluations demonstrate biochip assays achieving over 95% sensitivity and specificity in identifying protein biomarkers linked to breast, colon, and lung cancers. This high reliability empowers clinicians to design individualized treatment plans and adjust therapies based on a patient's molecular signature. As precision medicine initiatives expand, the integration of biochips with AI-driven analytics offers even richer insights, helping to predict treatment response and patient outcomes more effectively.

Key Market Challenges

High Chances of Biohacking and Privacy Concern

Biochips, tiny devices inserted into the hands, have revolutionized daily routines by expediting tasks. These cutting-edge chips offer a multitude of benefits, such as seamless access to homes, gyms, and offices, along with the convenience of storing emergency contacts, social media profiles, and e-tickets. Notably, Sweden has witnessed a surge in individuals opting to have these microchips implanted in their hands. However, scientists have raised concerns regarding potential data breaches and hacking vulnerabilities associated with biochips. These chips have the capability to track locations, monitor spending habits, and even record driving behaviors, making them susceptible to unauthorized access. Moreover, the presence of chips inside the body poses infection risks and raises questions about individual freedom. In response to these concerns, the United States has recently implemented regulations to prohibit the forced usage of biochips. It is anticipated that the market's revenue growth may face constraints due to the risks of biohacking and privacy concerns. The need for enhanced security measures and addressing privacy issues is crucial for the sustainable growth of this innovative industry.

Key Market Trends

Increasing Adoption of Biochips For Detecting Allergies

Many individuals have encountered various types of allergies, such as food, pollen, and others, resulting in a range of symptoms including fever, skin reactions, vomiting, asthma, and diarrhea. To address these issues, the field of allergy testing has witnessed the emergence of a remarkable new technology known as allergy testing biochips. This technology is currently experiencing significant growth and involves the use of microarrays that contain different allergen components. By utilizing these biochips, healthcare professionals are able to investigate patient-specific sensitization patterns in a single measurement, thus enhancing the accuracy and efficiency of allergy diagnoses.

Furthermore, the potential of biochips in allergy research has prompted companies to invest in the development of new technologies. For example, in April 2021, Toray Industries made an announcement regarding the successful development of allergy testing biochips capable of detecting multiple allergen-specific immunoglobin E (IgE) antibodies from trace amounts of blood. This breakthrough innovation holds tremendous promise for improving the precision and effectiveness of allergy testing.

The increasing adoption of biochips for detecting and testing allergens is expected to be a major driver for revenue growth in the allergy testing market throughout the forecast period. As more healthcare providers and researchers recognize the advantages offered by this advanced technology, its widespread implementation will revolutionize the field of allergy diagnostics, leading to improved patient care and outcomes.

Key Market Players

• Abbott Laboratories Inc.
• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• Fluidigm Corporation
• Thermo Fisher Scientific Inc.
• PerkinElmer Inc.
• Illumina Inc.
• Phalanx Biotech Group Inc.
• BioMerieux SA
• Qiagen NV

Report Scope:

In this report, the Global Biochip Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biochip Market, By Technology:

• Microarray
• Microfluidics

Biochip Market, By Type:

• DNA Chips
• Lab-On-a-Chips
• Protein Chips
• Others

Biochip Market, By Application:

• Drug Discovery & Development
• Disease Diagnostics
• Genomics
• Proteomics
• In-vitro diagnostics
• Others

Biochip Market, By End User:

• Hospitals & Diagnostics Centres
• Academic & Research Institutes
• Biotechnology & Pharmaceutical Companies
• Others

Biochip Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Biochip Market.

Available Customizations:

Global Biochip market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biochip Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technology (Microarray v/s Microfluidics)
  • 5.2.2. By Type (DNA Chips, Lab-On-a-Chips, Protein Chips, Others)
  • 5.2.3. By Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, In-vitro diagnostics and Others)
  • 5.2.4. By End User (Hospitals & Diagnostics Centers, Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Biochip Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technology
  • 6.2.2. By Type
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Biochip Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technology
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Biochip Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technology
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Biochip Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technology
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Biochip Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technology
  • 7.2.2. By Type
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Biochip Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technology
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. United Kingdom Biochip Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technology
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. Italy Biochip Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technology
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. France Biochip Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technology
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Biochip Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technology
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia-Pacific Biochip Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technology
  • 8.2.2. By Type
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Biochip Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technology
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Biochip Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technology
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Biochip Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technology
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Biochip Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technology
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Biochip Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technology
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. South America Biochip Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technology
  • 9.2.2. By Type
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Biochip Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technology
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Biochip Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technology
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Biochip Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technology
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. Middle East and Africa Biochip Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technology
  • 10.2.2. By Type
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Biochip Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technology
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Biochip Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technology
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Biochip Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technology
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Products Launches

13. Global Biochip Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Abbott Laboratories Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Agilent Technologies Inc.
• 15.3. Bio-Rad Laboratories Inc.
• 15.4. Fluidigm Corporation
• 15.5. Thermo Fisher Scientific Inc.
• 15.6. PerkinElmer Inc.
• 15.7. Illumina Inc.
• 15.8. Phalanx Biotech Group Inc.
• 15.9. BioMerieux SA
• 15.10. Qiagen NV

16. Strategic Recommendations

17. About Us & Disclaime